Skip to main content
SpringerLink
Log in

Hormonal Evaluation and Therapy in Erectile Dysfunction

  • Chapter
  • First Online:
Contemporary Treatment of Erectile Dysfunction

Part of the book series: Contemporary Endocrinology ((COE))

  • 1047 Accesses

Abstract

Although endocrine causes of erectile dysfunction (ED) have been well recognized for decades, historically there has been little emphasis on endocrine evaluation or treatment for men with ED. Endocrine abnormalities as a cause or contributing factor for ED are important to recognize since these may be associated with significant additional medical problems, and also because correction of the endocrinopathy often leads to improvement or resolution of ED.

This chapter reviews the endocrine causes of ED, and provides a practical approach to the endocrine evaluation and treatment of men with ED. A major emphasis of this chapter is related to testosterone deficiency, which may contribute to ED at various levels, including the brain, peripheral nerves, vasculature, and penis. Testosterone deficiency is becoming increasingly recognized as an important health issue for aging men, with a high prevalence among the age groups at risk for development of ED. Testosterone therapy in these men may resolve ED completely, or may allow for greater responsiveness to more traditional therapies, such as the oral phosphodiesterase 5 inhibitors. A basic hormonal evaluation should be considered for all men presenting with sexual dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Goldstein, A. M., & Padma-Nathan, H. (1990). The microarchitecture of the intracavernosal smooth muscle and the cavernosal fibrous skeleton. Journal d’Urologie, 144, 1144–1146.

    CAS  Google Scholar 

  2. Morales, A., Buvat, J., Gooren, L. J., Guay, A. T., Kaufman, J., Tan, H. M., et al. (2004). Endocrine aspects of sexual dysfunction in men. The Journal of Sexual Medicine, 1, 69–81.

    CAS  PubMed  Google Scholar 

  3. Wang, C., Nieschlag, E., Swerdloff, R., Behre, H. M., Hellstrom, W. J., Gooren, L. J., et al. (2008). Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. European Journal of Endocrinology, 159, 507–514.

    CAS  PubMed  Google Scholar 

  4. Bayliss, W. M., & Starling, E. H. (1902). The mechanism of pancreatic secretion. Journal de Physiologie, 28, 325–353.

    CAS  Google Scholar 

  5. Bhasin, S., & Jameson, J. L. (2008). Part 15, Chapter 340. Disorders of the testes and male reproductive system. In A. S. Fauci, E. Braunwald, D. L. Kasper, S. L. Hauser, D. L. Longo, J. L. Jameson, & J. Loscalzo (Eds.), Harrison’s principles of internal medicine (17th ed., pp. 2310–2323). New York: McGraw-Hill.

    Google Scholar 

  6. Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., et al. (2006). Testosterone therapy in adult men with androgen deficiency syndromes: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 91, 1995–2010.

    CAS  PubMed  Google Scholar 

  7. Matsumoto, A. M. (2001). The testis. In P. Felig & L. A. Frohman (Eds.), Endocrinolog and metabolism (4th ed., pp. 635–705). New York: McGraw-Hill.

    Google Scholar 

  8. Mills, T. M., Reilly, C. M., & Lewis, R. W. (1996). Androgens and penile erection: A review. Journal of Andrology, 17, 633–638.

    CAS  PubMed  Google Scholar 

  9. Mills, T. M., & Lewis, R. W. (1999). The role of andorgens in the erectile response: A 1999 perspective. Molecular Urology, 3, 75–86.

    CAS  PubMed  Google Scholar 

  10. Mills, T. M., Stopper, V. S., & Wiedmeier, V. T. (1994). Effects of castration and androgen replacement on the hemodynamics of penile erection in the rat. Biology of Reproduction, 51, 234–238.

    CAS  PubMed  Google Scholar 

  11. Shabsigh, R. (1997). The effects of testosterone on the cavernous tissue and erectile function. World Journal of Urology, 15, 21–26.

    CAS  PubMed  Google Scholar 

  12. Penson, D. F., Ng, C., Cai, L., Rajfer, J., & González-Cadavid, N. F. (1996). Androgen and pituitary control of penile nitric oxide synthase and erectile function in the rat. Biology of Reproduction, 55, 567–574.

    CAS  PubMed  Google Scholar 

  13. Morgentaler, A., & Crews, D. (1978). Role of the anterior hypothalamus-preoptic area in the regulation of reproductive behavior in the lizard, Anolis carolinensis: Implantation studies. Hormones and Behavior, 11, 61–73.

    Google Scholar 

  14. Suzuki, N., Sato, Y., Hisasue, S., Kato, R., Suzuki, K., & Tsukamoto, T. (2007). Effect of testosterone on intracavernous pressure elicited with electrical stimulation of the medial preoptic area and cavernous nerve in male rats. Journal of Andrology, 28, 218–222.

    CAS  PubMed  Google Scholar 

  15. Zhang, X. H., Filippi, S., Morelli, A., Vignozzi, L., Luconi, M., Donati, S., et al. (2006). Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. The Journal of Sexual Medicine, 3, 253–264.

    CAS  PubMed  Google Scholar 

  16. Redouté, J., Stoléru, S., Pugeat, M., Costes, N., Lavenne, F., Le Bars, D., et al. (2005). Brain processing of visual sexual stimuli in treated and untreated hypogonadal patients. Psychoneuroendocrinology, 30, 461–482.

    PubMed  Google Scholar 

  17. Kwan, M., Greeleaf, W. J., Mann, J., Crapo, L., & Davidson, J. M. (1983). The nature of androgen action on male sexuality: A combined laboratory-self-report study on hypogonadal men. The Journal of Clinical Endocrinology and Metabolism, 57, 557–562.

    CAS  PubMed  Google Scholar 

  18. Lewis, R. W., & Mills, T. M. (2004). Effect of androgens on penile tissue. Endocrine, 23, 101–105.

    CAS  PubMed  Google Scholar 

  19. Baba, K., Yajima, M., Carrier, S., Akkus, E., Reman, J., Nunes, L., et al. (2000). Effect of testosterone on the number of NADPH diaphorase-stained nerve fibers in the rat corpus cavernosum and dorsal nerve. Urology, 56, 533–538.

    CAS  PubMed  Google Scholar 

  20. Baba, K., Yajima, M., Carrier, S., Morgan, D. M., Nunes, L., Lue, T. F., et al. (2000). Delayed testosterone replacement restores nitric oxide synthase-containing nerve fibres and the erectile response in rat penis. BJU International, 85, 953–958.

    CAS  PubMed  Google Scholar 

  21. Armagan, A., Hatsushi, K., & Toselli, P. (2008). The effects of testosterone deficiency on the structural integrity of the penile dorsal nerve in the rat. International Journal of Impotence Research, 20, 73–78.

    CAS  PubMed  Google Scholar 

  22. Rogers, R. S., Graziottin, T. M., Lin, C. M., Kan, Y. W., & Lue, T. (2003). Intracavernosal vascular endothelial growth factor (VEGF) injection and adenoassociated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. International Journal of Impotence Research, 15, 26–37.

    CAS  PubMed  Google Scholar 

  23. Traish, A. M., Goldstein, I., & Kim, N. N. (2007). Testosterone and erectile function: From basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. European Urology, 52, 54–70.

    CAS  PubMed  Google Scholar 

  24. Giuliano, F., Rampin, O., Schirar, A., Jardin, A., & Rousseau, J. P. (1993). Autonomic control of penile erection: Modulation by testosterone in the rat. Journal of Neuroendocrinology, 5, 677–683.

    CAS  PubMed  Google Scholar 

  25. Meusburger, S. M., & Keast, J. R. (2001). Testosterone and nerve growth factor have distinct but interacting effects on structure and neurotransmitter expression of adult pelvic ganglion cells in vitro. Neuroscience, 108, 331–340.

    CAS  PubMed  Google Scholar 

  26. Keast, J. R., Gleeson, R. J., Shulkes, A., & Morris, M. J. (2002). Maturational and maintenance effects of testosterone on terminal axon density and neuropeptide expression in the rat vas deferens. Neuroscience, 112, 391–398.

    CAS  PubMed  Google Scholar 

  27. Rajfer, J., Aronson, W. J., Bush, P. A., Dorey, F. J., & Ignarro, L. J. (1992). Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. The New England Journal of Medicine, 326, 90–94.

    CAS  PubMed  Google Scholar 

  28. Burnett, A. L., Lowenstein, C. J., Bredt, D. S., Chang, T. S., & Snyder, S. H. (1992). Nitric oxide: A physiologic mediator of penile erection. Science, 257, 401–403.

    CAS  PubMed  Google Scholar 

  29. Lugg, J. A., Rajfer, J., & Gonzalez-Cadavid, N. F. (1995). Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the rat. Endocrinology, 136, 1495–1501.

    CAS  PubMed  Google Scholar 

  30. Edwards, E., Hamilton, J., & Duntley, S. (1939). Testosterone propionate as a therapeutic agent in patients with organic disease of peripheral vessels. The New England Journal of Medicine, 220, 865–869.

    Google Scholar 

  31. Akishita, M., Hashimoto, M., Ohine, Y., Ogawa, S., Iljima, K., Eto, M., et al. (2007). Low T level is an independent determinant of endothelial dysfunction in men. Hypertension Research, 30, 1029–1034.

    CAS  PubMed  Google Scholar 

  32. Traish, A. M., & Guay, A. T. (2006). Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. The Journal of Sexual Medicine, 3, 382–404.

    CAS  PubMed  Google Scholar 

  33. Seo, S. I., Kim, S. W., & Paick, J. S. (1999). The effects of androgen on penile reflex, erectile response to electrical stimulation and penile NOS activity in the rat. Asian Journal of Andrology, 1, 169–174.

    CAS  PubMed  Google Scholar 

  34. Schirar, A., Bonnefond, C., Meusnier, C., & Devinoy, E. (1997). Androgens modulate nitric oxide synthase messenger ribonucleic acid expression in neurons of the major pelvic ganglion in the rat. Endocrinology, 138, 3093–3102.

    CAS  PubMed  Google Scholar 

  35. Traish, A. M. (2009). Androgens play a pivotal role in maintaining penile tissue architecture and erection: A review. Journal of Andrology, 30(4), 363–369.

    CAS  PubMed  Google Scholar 

  36. Aversa, A., Isidori, A. M., De Martino, M. U., Caprio, M., Fabbrini, E., Rochietti-March, M., et al. (2000). Androgens and penile erection: Evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction. Clinical Endocrinology, 53, 517–522.

    CAS  PubMed  Google Scholar 

  37. Aversa, A., Isidori, A. M., Spera, G., Lenzi, A., & Fabbri, A. (2003). Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clinical Endocrinology, 58, 632–638.

    CAS  PubMed  Google Scholar 

  38. Cunningham, G. R., & Hirshkowitz, M. (1995). Inhibition of steroid 5 alphareductase with finasteride: Sleep-related erections, potency, and libido in healthy men. The Journal of Clinical Endocrinology and Metabolism, 80, 1934–1940.

    CAS  PubMed  Google Scholar 

  39. Yassin, A. A., Saad, F., & Diede, H. E. (2006). Testosterone and erectile function in hypogonadal men unresponsive to tadalafil: Results from an open-label uncontrolled study. Andrologia, 38, 61–68.

    CAS  PubMed  Google Scholar 

  40. Reilly, C. M., Stopper, V. S., & Mills, T. M. (1997). Androgens modulate the alpha-adrenergic responsiveness of vascular smooth muscle in the corpus cavernosum. Journal of Andrology, 18, 26–31.

    CAS  PubMed  Google Scholar 

  41. Mills, T. M., Dai, Y., Stopper, V. S., & Lewis, R. W. (1999). Androgenic maintenance of the erectile response in the rat. Steroids, 64, 605–609.

    CAS  PubMed  Google Scholar 

  42. Traish, A. M., Park, K., Dhir, V., Kim, N. N., Moreland, R. B., & Goldstein, I. (1999). Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology, 140, 1861–1868.

    CAS  PubMed  Google Scholar 

  43. Traish, A. M., Munarriz, R., O’Connell, L., Choi, S., Kim, S. W., Kim, N. N., et al. (2003). Effects of medical or surgical castration on erectile function in an animal model. Journal of Andrology, 24, 381–387.

    PubMed  Google Scholar 

  44. Bhasin, S., Taylor, W. E., Singh, R., Artaza, J., Sinha-Hikim, I., Jasuja, R., et al. (2003). The mechanisms of androgen effects on body composition: Mesenchymal pluripotent cell as the target of androgen action. The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 58, M1103–M1110.

    Google Scholar 

  45. Singh, R., Artaza, J. N., Taylor, W. E., Gonzalez-Cadavid, N. F., & Bhasin, S. (2003). Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology, 144, 5081–5088.

    CAS  PubMed  Google Scholar 

  46. Singh, R., Artaza, J. N., Taylor, W. E., Braga, M., Yuan, X., Gonzalez-Cadavid, N. F., et al. (2006). Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: Nuclear translocation of androgen receptor complex with betacatenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology, 147, 141–154.

    CAS  PubMed  Google Scholar 

  47. Foresta, C., Caretta, N., Lana, A., De Toni, L., Biagioli, A., Ferlin, A., et al. (2006). Reduced number of circulating endothelial progenitor cells in hypogonadal men. The Journal of Clinical Endocrinology and Metabolism, 91, 4599–4602.

    CAS  PubMed  Google Scholar 

  48. Persson, C., Diederichs, W., Lue, T. F., Yen, T. S. B., Fishman, I. J., Mclin, P., et al. (1989). Correlation of altered penile ultrastructure with clinical arterial evaluation. Journal d’Urologie, 142, 1462–1468.

    CAS  Google Scholar 

  49. Traish, A., & Kim, N. (2005). The physiological role of androgens in penile erection: Regulation of corpus cavernosum structure and function. The Journal of Sexual Medicine, 2, 759–770.

    CAS  PubMed  Google Scholar 

  50. Shabsigh, R., Raymond, J. F., Olsson, C. A., O’Toole, K., & Buttyan, R. (1998). Androgen induction of DNA synthesis in the rat penis. Urology, 52, 723–728.

    CAS  PubMed  Google Scholar 

  51. Traish, A. M., Toselli, P., Jeong, S. J., & Kim, N. N. (2005). Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: A potential mechanism for veno-occlusive dysfunction in androgen deficiency. Journal of Andrology, 26, 242–248.

    PubMed  Google Scholar 

  52. Yassin, A. A., & Saad, F. (2008). Testosterone and erectile dysfunction. Journal of Andrology, 29, 593–604.

    CAS  PubMed  Google Scholar 

  53. Nehra, A., Goldstein, I., Pabby, A., Nugent, M., Huang, Y. H., de las Morenas, A., et al. (1996). Mechanisms of venous leakage: A prospective clinicopathological correlation of corporeal function and structure. Journal d’Urologie, 156, 1320–1329.

    CAS  Google Scholar 

  54. Moreland, R. B. (1998). Is there a role of hypoxemia in penile fibrosis: A viewpoint presented to the society for the study of impotence. International Journal of Impotence Research, 10, 113–120.

    CAS  PubMed  Google Scholar 

  55. Mersdorf, A., Goldsmith, P. C., Diederichs, W., Padula, C. A., Lue, T. F., Fishman, I. J., et al. (1991). Ultrastructural changes in impotent penile tissue: A comparison of 65 patients. Journal d’Urologie, 145, 749–758.

    CAS  Google Scholar 

  56. Traish, A. M., & Kim, N. N. (2005). Weapons of penile smooth muscle destruction: Androgen deficiency promotes accumulation of adipocytes in the corpus cavernosum. The Aging Male, 8, 141–146.

    CAS  PubMed  Google Scholar 

  57. Nehra, A., Azadzoi, K. M., Moreland, R. B., Pabby, A., Siroky, M. B., Krane, R. J., et al. (1998). Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction. Journal d’Urologie, 159, 2229–2236.

    CAS  Google Scholar 

  58. Wespes, E., Sattar, A. A., Golzarian, J., Wery, D., Daoud, N., & Schulman, C. C. (1997). Corporeal veno-occlusive dysfunction: Predominantly intracavernous muscular pathology. Journal d’Urologie, 157, 1678–1680.

    CAS  Google Scholar 

  59. Wespes, E., Raviv, G., Vanegas, J. P., Decaestecker, C., Petein, M., Danguy, A., et al. (1998). Corporeal veno-occlusive dysfunction: A distal arterial pathology? Journal d’Urologie, 160, 2054–2057.

    CAS  Google Scholar 

  60. Natoli, A. K., Medley, T. L., Ahimastos, A. A., Drew, B. G., Thearle, D. J., Dilley, R. J., et al. (2005). Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression. Hypertension, 46, 1129–1134.

    CAS  PubMed  Google Scholar 

  61. Simpson, S., & Marshal, F. H. A. (1908). On the effects of stimulating the nervi erigentes in castrated animals. Quarterly Journal of Experimental Physiology, 1, 257–259.

    Google Scholar 

  62. Palese, M. A., Crone, J. K., & Burnett, A. L. (2003). A castrated mouse model of erectile dysfunction. Journal of Andrology, 24, 699–703.

    PubMed  Google Scholar 

  63. Bivalacqua, T. J., Rajasekaran, M., Champion, H. C., Wang, R., Sikka, S. C., Kadowitz, P. J., et al. (1998). The influence of castration on pharmacologically induced penile erection in the cat. Journal of Andrology, 19, 551–557.

    CAS  PubMed  Google Scholar 

  64. Müller, S. C., Hsieh, J. T., Lue, T. F., & Tanagho, E. A. (1988). Castration and erection. An animal study. European Urology, 15, 118–124.

    PubMed  Google Scholar 

  65. Heaton, J. P., & Varrin, S. J. (1994). Effects of castration and exogenous testosterone supplementation in an animal model of penile erection. Journal d’Urologie, 151, 797–800.

    CAS  Google Scholar 

  66. Takahashi, Y., Hirata, Y., Yokoyama, S., Ishii, N., Nunes, L., Lue, T. F., et al. (1991). Loss of penile erectile response to intracavernous injection of acetylcholine in castrated dog. The Tohoku Journal of Experimental Medicine, 163, 85–91.

    CAS  PubMed  Google Scholar 

  67. Karadeniz, T., Topsakal, M., Aydogmus, A., Gülgün, C., Aytekin, Y., & Basak, D. (1996). Correlation of ultrastructural alterations in cavernous tissue with the clinical diagnosis vasculogenic impotence. Urologia Internationalis, 57, 58–61.

    CAS  PubMed  Google Scholar 

  68. Davila, H. H., Rajfer, J., & Gonzalez-Cadavid, N. F. (2004). Corporal veno-occlusive dysfunction in aging rats: Evaluation by cavernosometry and cavernosography. Urology, 64, 1261–1266.

    CAS  PubMed  Google Scholar 

  69. Shen, Z. J., Zhou, X. L., Lu, Y. L., & Chen, Z. D. (2003). Effect of androgen deprivation on penile ultrastructure. Asian Journal of Andrology, 5, 33–36.

    CAS  PubMed  Google Scholar 

  70. Tancredi, A., Reginster, J. Y., Schleich, F., Pire, G., Maassen, P., Luyckx, F., et al. (2004). Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers. European Journal of Endocrinology, 151, 355–360.

    CAS  PubMed  Google Scholar 

  71. Heinemann, L. A., Saad, F., Heinemann, K., & Thai, D. M. (2004). Can results of the Aging Males’ Symptoms (AMS) scale predict those of screening scales for androgen deficiency? The Aging Male, 7, 211–218.

    CAS  PubMed  Google Scholar 

  72. Smith, K. W., Feldman, H. A., & McKinlay, J. B. (2000). Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clinical Endocrinology, 53, 703–711.

    CAS  PubMed  Google Scholar 

  73. Corona, G., Mannucci, E., Petrone, L., Balercia, G., Fisher, A. D., Chiarini, V., et al. (2006). ANDROTEST: A structured interview for the screening of hypogonadism in patients with sexual dysfunction. The Journal of Sexual Medicine, 3, 706–715.

    PubMed  Google Scholar 

  74. Moreno, S. A., & Morgentaler, A. (2009). Testosterone deficiency and Peyronie’s disease: pilot data suggesting a significant relationship. The Journal of Sexual Medicine, 6, 1729–1735.

    CAS  PubMed  Google Scholar 

  75. Zitzmann, M., Faber, S., & Nieschlag, E. (2006). Association of specific symptoms and metabolic risks with serum testosterone in older men. The Journal of Clinical Endocrinology and Metabolism, 91, 4335–4343.

    CAS  PubMed  Google Scholar 

  76. Lazarou, S., Reyes-Vallejo, L., & Morgentaler, A. (2006). Wide variability in laboratory reference values for serum testosterone. The Journal of Sexual Medicine, 3, 1085–1089.

    CAS  PubMed  Google Scholar 

  77. Morgentaler, A. (2007). Commentary: Guideline for male testosterone therapy – A clinician’s perspective. The Journal of Clinical Endocrinology and Metabolism, 92, 416–417.

    CAS  PubMed  Google Scholar 

  78. Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999). A critical evaluation of simple methods for the estimation of free testosterone in serum. The Journal of Clinical Endocrinology and Metabolism, 84, 3666–3672.

    CAS  PubMed  Google Scholar 

  79. Okamura, K., Ando, F., & Shimokata, H. (2005). Serum total and free testosterone level of Japanese men: A population-based study. International Journal of Urology, 12, 810–814.

    CAS  PubMed  Google Scholar 

  80. Moreno Sergio A., Shyam Anita., Morgentaler Abraham. (2010). Comparison of free testosterone results by analog radioimmunoassay and calculated free testosterone in an ambulatory clinical population). Journal of Sexual Medicine 7, 1948–1953.

    Google Scholar 

  81. Morgentaler, A., & Rhoden, E. L. (2006). Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less. Urology, 68, 1263–1267.

    PubMed  Google Scholar 

  82. Niskanen, L., Laaksonen, D. E., Punnonen, K., Mustajoki, P., Kaukua, J., & Rissanen, A. (2004). Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome. Diabetes, Obesity & Metabolism, 6, 208–215.

    CAS  Google Scholar 

  83. Kaukua, J., Pekkarinen, T., Sane, T., & Mustajoki, P. (2003). Sex hormones and sexual function in obese men losing weight. Obesity Research, 11, 689–694.

    CAS  PubMed  Google Scholar 

  84. Lue, T. F., Giuliano, F., Montorsi, F., Rosen, R. C., Andersson, K. E., Althof, S., et al. (2004). Summary of the recommendations on sexual dysfunctions in men. The Journal of Sexual Medicine, 1, 6–23.

    PubMed  Google Scholar 

  85. Lazarou, S., & Morgentaler, A. (2005). Hypogonadism in the man with erectile dysfunction: What to look for and when to treat. Current Urology Reports, 6, 476–481.

    PubMed  Google Scholar 

  86. Reyes-Vallejo, L., Lazarou, S., & Morgentaler, A. (2007). Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone. The Journal of Sexual Medicine, 4, 1757–1762.

    CAS  PubMed  Google Scholar 

  87. Isidori, A. M., Giannetta, E., Gianfrilli, D., Greco, E. A., Bonifacio, V., Aversa, A., et al. (2005). Effects of testosterone on sexual function in men: Results of a meta-analysis. Clinical Endocrinology, 63, 381–394.

    CAS  PubMed  Google Scholar 

  88. Boloña, E. R., Uraga, M. V., Haddad, R. M., Tracz, M. J., Sideras, K., Kennedy, C. C., et al. (2007). Testosterone use in men with sexual dysfunction: A systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clinic Proceedings, 82, 20–28.

    PubMed  Google Scholar 

  89. Kalinchenko, S. Y., Kozlov, G. I., Gontcharov, N. P., & Katsiya, G. V. (2003). Oral testosterone undeconate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone. The Aging Male, 6, 94–99.

    CAS  PubMed  Google Scholar 

  90. Shabsigh, R., Kaufman, J. M., Steidle, C., & Padma-Nathan, H. (2004). Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. Journal d’Urologie, 172, 658–663.

    CAS  Google Scholar 

  91. Greenstein, A., Mabjeesh, N. J., Sofer, M., Kaver, I., Matzkin, H., & Chen, J. (2005). Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed? Journal d’Urologie, 173, 530–532.

    CAS  Google Scholar 

  92. Hwang, T. I., Chen, H. E., Tsai, T. F., & Lin, Y. C. (2006). Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone. International Journal of Impotence Research, 18, 400–404.

    CAS  PubMed  Google Scholar 

  93. Gore, J. L., Swerdloff, R. S., & Rajfer, J. (2005). Androgen deficiency in the etiology and treatment of erectile dysfunction. The Urologic Clinics of North America, 32, 457–468. vi–vii.

    PubMed  Google Scholar 

  94. Rhoden, E. L., & Morgentaler, A. (2004). Risks of testosterone-replacement therapy and recommendations for monitoring. The New England Journal of Medicine, 350, 482–492.

    CAS  PubMed  Google Scholar 

  95. Gurbuz, N., Mammadov, E., & Usta, M. F. (2008). Hypogonadism and erectile dysfunction: An overview. Asian Journal of Andrology, 10, 36–43.

    CAS  PubMed  Google Scholar 

  96. Morgentaler, A. (2006). Testosterone and prostate cancer: An historical perspective on a modern myth. European Urology, 50, 935–939.

    CAS  PubMed  Google Scholar 

  97. Morgentaler, A., & Traish, A. M. (2009). The saturation model and the limits of androgen stimulation of prostate cancer. European Urology, 55, 310–321.

    PubMed  Google Scholar 

  98. Endogenous Hormones Prostate Cancer Collaborative Group, Roddam, A. W., Allen, N. E., Appleby, P., & Key, T. J. (2008). Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies. Journal of the National Cancer Institute, 100, 170–183.

    CAS  PubMed  Google Scholar 

  99. Bhasin, S., Enzlin, P., Coviello, A., & Basson, R. (2007). Sexual dysfunction in men and women with endocrine disorders. Lancet, 369, 597–611.

    CAS  PubMed  Google Scholar 

  100. Buvat, J. (2003). Hyperprolactinemia and sexual function in men: A short review. International Journal of Impotence Research, 15, 373–377.

    CAS  PubMed  Google Scholar 

  101. Morales, A., & Heaton, J. P. (2003). Hypogonadism and erectile dysfunction: Pathophysiological observations and therapeutic outcomes. BJU International, 92, 896–899.

    CAS  PubMed  Google Scholar 

  102. Delavierre, D., Girard, P., Peneau, M., & Ibrahim, H. (1999). Should plasma prolactin assay be routinely performed in the assessment of erectile dysfunction? Report of a series of 445 patients. Review of the literature. Progrès en Urologie, 9, 1097–1101.

    CAS  PubMed  Google Scholar 

  103. Buvat, J., & Lemaire, A. (1997). Endocrine screening in 1,022 men with erectile dysfunction: Clinical significance and costeffective strategy. Journal d’Urologie, 158, 1764–1767.

    CAS  Google Scholar 

  104. Rhoden, E. L., Estrada, C., Levine, L., & Morgentaler, A. (2003). The value of pituitary magnetic resonance imaging in men with hypogonadism. Journal d’Urologie, 170, 795–798.

    Google Scholar 

  105. De Rosa, M., Zarrilli, S., Vitale, G., Di Somma, C., Orio, F., Tauchmanova’, L., et al. (2004). Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: An open longitudinal study monitoring nocturnal penile tumescence. The Journal of Clinical Endocrinology and Metabolism, 89, 621–625.

    PubMed  Google Scholar 

  106. Coloa, A., Vitale, G., Cappabianca, P., Briganti, F., Ciccarelli, A., De Rosa, M., et al. (2004). Outcome of cabergoline treatment in men with prolactinoma: Effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. The Journal of Clinical Endocrinology and Metabolism, 89, 1704–1711.

    Google Scholar 

  107. Carani, C., Isidori, A. M., Granata, A., Carosa, E., Maggi, M., Lenzi, A., et al. (2005). Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. The Journal of Clinical Endocrinology and Metabolism, 90, 6472–6479.

    CAS  PubMed  Google Scholar 

  108. Mancini, A., Milardi, D., Bianchi, A., Summaria, V., & De Marinis, L. (2005). Increased estradiol levels in venous occlusive disorder: A possible functional mechanism of venous leakage. International Journal of Impotence Research, 17, 239–242.

    CAS  PubMed  Google Scholar 

  109. Lombardo, F., Gandini, L., Jannini, E. A., Sgrò, P., Gilio, B., Toselli, L., et al. (2005). Diagnosing erectile dysfunction: Instruments for endocrine diagnosis. International Journal of Andrology, 28(Suppl), 53–55.

    PubMed  Google Scholar 

  110. Cohen, L. M., Greenberg, D. B., & Murray, G. B. (1984). Neuropsychiatric presentation of men with pituitary tumors (the ‘four A’s’). Psychosomatics, 25, 925–928.

    CAS  PubMed  Google Scholar 

  111. Webb, S. M., Prieto, L., Badia, X., Albareda, M., Catala, M., Gaztambide, S., et al. (2002). Acromegaly Quality of Life Questionnaire (ACROQOL): A new health-related quality of life questionnaire for patients with acromegaly – Development and psychometric properties. Clinical Endocrinology, 57, 251–258.

    CAS  PubMed  Google Scholar 

  112. Merriam, G. R., Carney, C., Smith, L. C., & Kletke, M. (2004). Adult growth hormone deficiency: Current trends in diagnosis and dosing. Journal of Pediatric Endocrinology & Metabolism, 17(Suppl), 1307–1320.

    CAS  Google Scholar 

  113. Giannoulis, M. G., Sonksen, P. H., Umpleby, M., Breen, L., Pentecost, C., Whyte, M., et al. (2006). The effects of growth hormone and/or testosterone in healthy elderly men: A randomized controlled trial. The Journal of Clinical Endocrinology and Metabolism, 91, 477–484.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Harvard Medical School, Boston, MA, 02445, USA

    Abraham Morgentaler

  2. Men’s Health Boston, 1 Brookline Place, Brookline Place, Suite #624, Brookline, MA, 02445, USA

    Abraham Morgentaler

Authors
  1. Sergio A. Moreno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abraham Morgentaler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abraham Morgentaler .

Editor information

Editors and Affiliations

  1. Feinberg School of Medicine, Department of Urology, Northwestern University, East Chicago Avenue 303, Chicago, 60611-3008, Illinois, USA

    Kevin T. McVary

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Moreno, S.A., Morgentaler, A. (2011). Hormonal Evaluation and Therapy in Erectile Dysfunction. In: McVary, K. (eds) Contemporary Treatment of Erectile Dysfunction. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-60327-536-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-536-1_12

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-535-4

  • Online ISBN: 978-1-60327-536-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation